Opinion | The Warm-Up Hack Doctors Should Take From Pop Stars and Quarterbacks (Gift Article)
Doctors need to warm up too.
Related Articles
Search Cancer Clinical Trials | OSUCCC – James
Search open enrollments clinical trials at the OSUCCC – James. Find out the study’s criteria, whether you may be eligible and more here.
Lead Poisoning May Have Made Ancient Romans a Bit Less Intelligent
Exposure to lead from mining probably lowered I.Q. levels in the empire, research has found. It might be the world’s first case of widespread industrial…
Abortion Pills Prescribed by Pharmacists Are Newest Effort in Abortion Fight
Washington State’s program is the first, but other states are expected to try allowing pharmacists to prescribe the pills to counter growing efforts to curtail…
E10: Healthcare and Parenthood: Facing Infertility in a Demanding Career(W/Dr Ariela Marshall, MD)
In this conversation, Dr. Ariela Marshall joins host Dr. Saba Fatima to discuss the often-overlooked issue of infertility among women physicians, sharing her…
Screening for Iron Deficiency Could Benefit Many Women Who Might Go Undiagnosed
Blood tests to detect low iron levels may be a cost-effective way to diagnose and treat iron deficiency, a new study shows.
BLOG: Three women in oncology on running the inaugural Every Woman’s Marathon
On Nov. 16, 2024, more than 7,000 runners convened in Savannah, Georgia, for the inaugural Every Woman’s Marathon.While billed as the Every Woman’s Marathon, it…
Andexanet alfa: trials just leave us with more questions
ANNEXA-I, the first ever randomised controlled trial of a reversal agent for direct oral anticoagulants, was published in 2024. The trial, which randomised patients with…
First Bird Flu Death in U.S. Reported in Louisiana
The deceased was over 65 and had other medical conditions, state officials said.
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
PURPOSEDatopotamab deruxtecan (Dato-DXd) is a trophoblast cell-surface antigen-2–directed antibody-drug conjugate with a highly potent topoisomerase I inhibitor payload. The TROPION-Lung05 phase II trial (ClinicalTrials.gov identifier:…
